Llovet et al (2012) reported that plasma c-KIT and HGF are potential markers that predict response to sorafenib in HCC patients, although these results did not reach statistical significance.
← all excerpts
Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma.
1
—
—